Clinical trial
A Multicenter Non-Interventional Study Evaluating Bleeds and Health-Related Quality Of Life in Patients With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
NCT06883240 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Non-Interventional Study Evaluating Bleeds and Health-Related Quality Of Life in Patients With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 29, 2025
- Completion date
- November 1, 2026
- Enrollment
- 44 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.